79 related articles for article (PubMed ID: 3162299)
1. Peripartum heart failure in a patient treated previously with doxorubicin.
Davis LE; Brown CE
Obstet Gynecol; 1988 Mar; 71(3 Pt 2):506-8. PubMed ID: 3162299
[TBL] [Abstract][Full Text] [Related]
2. Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin.
Katz A; Goldenberg I; Maoz C; Thaler M; Grossman E; Rosenthal T
Am J Med Sci; 1997 Dec; 314(6):399-400. PubMed ID: 9413345
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma.
Longhi A; Ferrari S; Bacci G; Specchia S
Anticancer Drugs; 2007 Jul; 18(6):737-44. PubMed ID: 17762406
[TBL] [Abstract][Full Text] [Related]
4. Chemoresponsiveness of Moloney sarcoma virus-induced osteosarcoma to adriamycin in the rat.
Olson HM; Capen CC
Cancer Res; 1978 Jun; 38(6):1561-7. PubMed ID: 274173
[No Abstract] [Full Text] [Related]
5. [Biventricular heart failure in patient treated with anthracycline in childhood: myocardial dysfunction is not always the cause].
Iarussi D; Martino V; Iacono C; Indolfi P; Muto R; Calabrò R
Ital Heart J Suppl; 2004 Apr; 5(4):294-7. PubMed ID: 15185468
[TBL] [Abstract][Full Text] [Related]
6. Fatal congestive heart failure following mitoxantrone treatment in two children previously treated with doxorubicin and cisplatin.
Pratt CB; Crom DB; Wallenberg J; Sanyal SK; Miliauskas J; Sohlberg K
Cancer Treat Rep; 1983 Jan; 67(1):85-8. PubMed ID: 6684503
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
[TBL] [Abstract][Full Text] [Related]
9. [Heart failure in a subject treated with anthracyclines in childhood: myocardial dysfunction is not always the only reason of it].
Iarussi D; Martino V; Iacono C; Indolfi P; Muto R; Calabrò R
Ital Heart J Suppl; 2004 Apr; 5(4):294-7. PubMed ID: 15346697
[TBL] [Abstract][Full Text] [Related]
10. [Congestive cardiomyopathy after doxorubicin (adriamycin)author's transl)].
Kaduk B; Seiler G
Dtsch Med Wochenschr; 1977 Dec; 102(49):1813-7. PubMed ID: 271071
[TBL] [Abstract][Full Text] [Related]
11. Reversible doxorubicin-induced congestive heart failure.
Cohen M; Kronzon I; Lebowitz A
Arch Intern Med; 1982 Aug; 142(8):1570-1. PubMed ID: 7103641
[TBL] [Abstract][Full Text] [Related]
12. Perioperative cardiovascular collapse in a patient previously treated with doxorubicin.
Borgeat A; Chioléro R; Baylon P; Freeman J; Neff R
Anesth Analg; 1988 Dec; 67(12):1189-91. PubMed ID: 3257094
[No Abstract] [Full Text] [Related]
13. A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma.
McTiernan A; Meyer T; Michelagnoli MP; Lewis I; Whelan JS
Pediatr Blood Cancer; 2006 Mar; 46(3):345-50. PubMed ID: 16206197
[TBL] [Abstract][Full Text] [Related]
14. Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
Gallegos-Castorena S; Martínez-Avalos A; Mohar-Betancourt A; Guerrero-Avendaño G; Zapata-Tarrés M; Medina-Sansón A
Pediatr Hematol Oncol; 2007 Sep; 24(6):403-8. PubMed ID: 17710657
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin in experimental and clinical heart failure.
Christiansen S; Autschbach R
Eur J Cardiothorac Surg; 2006 Oct; 30(4):611-6. PubMed ID: 16901709
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
[TBL] [Abstract][Full Text] [Related]
17. Familial peripartum cardiomyopathy after molar pregnancy.
Massad LS; Reiss CK; Mutch DG; Haskel EJ
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):886-8. PubMed ID: 8469509
[TBL] [Abstract][Full Text] [Related]
18. Rationale for the use of mitoxantrone in the older patient: cardiac toxicity.
Benjamin RS
Semin Oncol; 1995 Feb; 22(1 Suppl 1):11-3. PubMed ID: 7863345
[No Abstract] [Full Text] [Related]
19. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.
Patel SR; Papadopolous N; Raymond AK; Donato M; Seong CM; Yasko AW; Lewis VO; Lin PP; Champlin R; Benjamin RS
Cancer; 2004 Jul; 101(1):156-63. PubMed ID: 15222001
[TBL] [Abstract][Full Text] [Related]
20. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.
van Dalen EC; van der Pal HJ; van den Bos C; Kok WE; Caron HN; Kremer LC
Eur J Cancer; 2006 Oct; 42(15):2549-53. PubMed ID: 16919450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
